Zobrazeno 1 - 10
of 116
pro vyhledávání: '"Fikret, Arpaci"'
Autor:
Birol Yildiz, Ismail Erturk, Nuri Karadurmus, Zeki Gokhan Surmeli, Ece Esin, Sukru Ozaydinli, Bilgin Bahadir Basgoz, Fikret Arpaci
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 2, Pp 70-73 (2018)
Aim: Even though ABO blood group surface antigens are expressed in red blood cells, they can be observed in many normal and pathologic cells. Relationship between ABO blood groups and progression and prognosis of cancer has been mainly demonstrated i
Externí odkaz:
https://doaj.org/article/f6a1186e9c2948338cb9d6f1755429ec
Autor:
Gokhan Erdem, Nuri Karadurmus, Sukru Ozaydin, Ibrahim Demirci, Bilgin Bahadir Basgoz, İsmail Ertürk, Birol Yıldız, Ramzan Ocal, Fikret Arpaci
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 29-34 (2018)
Background: Lung involvement, an uncommon initial presentation of Hodgkin Lymphoma (HL), may appear as primary or secondary pulmonary HL. Although the combination of Brentuximab vedotin (BV) with AVD is suggested as an alternative treatment to combin
Externí odkaz:
https://doaj.org/article/1d537572ca9c4655b232a11086d56df5
Publikováno v:
International Journal of Hematology-Oncology and Stem Cell Research, Vol 12, Iss 2 (2018)
Breast cancer (BC) has a high mortality rate and metastatic BC is almost incurable despite hormonal therapy and chemotherapy. The second and third lines of chemotherapies usually yield transient responses and the median survival is generally as low a
Externí odkaz:
https://doaj.org/article/7923d0b6b0834d2d8b71307cdb16ad9b
Autor:
Musa Baris Aykan, Halil Kizilöz, Galip Buyukturan, Gokhan Erdem, Ramazan Esen, Ramazan Acar, Yuksel Urun, Fikret Arpaci, Ismail Erturk, Birol Yildiz, Nuri Karadurmus
Publikováno v:
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 27(7)
Introduction and aim To demonstrate the real-life data about patients who underwent AHSCT due to GCT. Methods Between November 2016 and April 2020, 64 patients who received CE as high-dose chemotherapy for AHSCT in the Gulhane Education and Research
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4dede5e5777cd38ae62ab92236418a6a
https://pubmed.ncbi.nlm.nih.gov/33446059
https://pubmed.ncbi.nlm.nih.gov/33446059
Autor:
Sukru Ozaydinli, Fikret Arpaci, Bilgin Bahadir Basgoz, Birol Yildiz, Nuri Karadurmus, Ece Esin, Zeki Gokhan Surmeli, Ismail Erturk
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 2, Pp 70-73 (2018)
Aim: Even though ABO blood group surface antigens are expressed in red blood cells, they can be observed in many normal and pathologic cells. Relationship between ABO blood groups and progression and prognosis of cancer has been mainly demonstrated i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ee3c378deb610adda06b08be2cb2b8
https://doi.org/10.1016/j.jons.2018.01.004
https://doi.org/10.1016/j.jons.2018.01.004
Autor:
Bilgin Bahadir Basgoz, Ramzan Ocal, Sukru Ozaydin, Ibrahim Demirci, Fikret Arpaci, Gokhan Erdem, Ismail Erturk, Nuri Karadurmus, Birol Yildiz
Publikováno v:
Journal of Oncological Sciences, Vol 4, Iss 1, Pp 29-34 (2018)
Background: Lung involvement, an uncommon initial presentation of Hodgkin Lymphoma (HL), may appear as primary or secondary pulmonary HL. Although the combination of Brentuximab vedotin (BV) with AVD is suggested as an alternative treatment to combin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::72877d249537380913e3b02de1565453
https://doi.org/10.1016/j.jons.2017.10.006
https://doi.org/10.1016/j.jons.2017.10.006
Autor:
Selmin Ataergin, Fikret Arpaci, Kaan Erler, Bahtiyar Demiralp, Ilker Cicek, Cuneyt Ulutin, Luis Solchaga, Ayhan Ozcan
Publikováno v:
Clinical Medicine Insights: Oncology, Vol 1 (2007)
We present a 20-year-old male patient with localized osteosarcoma arising in osteogenesis imperfecta who underwent high-dose chemotherapy together with autologous peripheral blood stem cell transplantation followed-by a successful extremity sparing s
Externí odkaz:
https://doaj.org/article/5451cbed1b8940a4adf40cae2d248ae0
Autor:
Mustafa Öztürk, Gokhan Erdem, Gürkan Mert, Ramazan Gümral, Fikret Arpaci, Nuri Karadurmus, Ismail Erturk, Sukru Ozaydin, Birol Yildiz, Selmin Ataergin
Publikováno v:
British Journal of Medicine and Medical Research. 19:1-5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c1fa285e019ef12c75b2547e924713c
https://doi.org/10.9734/bjmmr/2017/24556
https://doi.org/10.9734/bjmmr/2017/24556
Autor:
Sukru Ozaydin, Deniz Dogan, Birol Yildiz, Nuri Karadurmus, Mustafa Öztürk, Hayati Bilgiç, Fikret Arpaci, Ramazan Öcal, Nesrin Öcal
Publikováno v:
OncoTargets and therapy
Nesrin Ocal,1 Birol Yildiz,2 Nuri Karadurmus,2 Deniz Dogan,1 Sukru Ozaydin,2 Ramazan Ocal,3 Mustafa Ozturk,2 Fikret Arpaci,4 Hayati Bilgic1 1Department of Chest Diseases, 2Department of Oncology, Gulhane Military Medical Faculty, Ankara, Turkey; 3Dep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4a87b9f56f0b61ace608547a8d70ffa
https://doi.org/10.2147/ott.s107899
https://doi.org/10.2147/ott.s107899
Publikováno v:
World Journal of Transplantation
Solid tumors in adults constitute a heterogeneous group of malignancy originating from various organ systems. Solid tumors are not completely curable by chemotherapy, even though some subgroups are very chemo-sensitive. Recently, oncologists have foc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53ddd0e83490293189e7bddfa061b18c
http://europepmc.org/articles/PMC5175225
http://europepmc.org/articles/PMC5175225